Clinical Trial Update: Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study of topical AP611074 Gel for treating genital warts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Condylomata Acuminata
• Genital Warts
• Human Papillomavirus Infection

Drugs mentioned

• AP611074 Gel (AP-611074)

Snippet

Sponsor: Anaconda Pharma | Conditions: Anogenital Warts, Condylomata Acuminata | Phase 1, Phase 2 | Status: COMPLETED